Automated Cell Therapy
-
Coeptis Therapeutics’ Dave Mehalick on the disruptive potential of SNAP-CAR technology for autoimmune diseases
In an insightful interview with Tracy Weslosky, Dave Mehalick, Chairman, President, and CEO of Coeptis Therapeutics Holdings, Inc.…
-
Hemostemix’s stem cell therapy pursues ‘Your Fountain of Youth’
What’s a company worth to investors that could improve numerous medical conditions related to ischemia (lack of blood…
